Literature DB >> 1470605

Villous culture of first trimester human placenta--model to study extravillous trophoblast (EVT) differentiation.

O Genbacev1, S A Schubach, R K Miller.   

Abstract

During implantation and subsequent placentation the human extravillous trophoblast (EVT) cells invade the endometrium and maternal vasculature within the uterus. The origin of the EVT and signals triggering its differentiation, migration and invasion are poorly understood. First and second trimester human chorionic villi explants were used as a source of EVT and a variety of substrates which resemble extracellular matrix (ECM) in vivo have been tested to induce EVT differentiation and migration. The obtained results demonstrate that villous explants from both 5-7 and 8-10 weeks of gestation give rise to EVT cells in vitro if maintained on the surface of Matrigel or decidual extract supplemented collagen gel. Fetal calf serum (FCS) supplemented media was essential for EVT differentiation and villous trophoblast viability. Immunostaining of both EVT cells and cells from the cytotrophoblastic column with monoclonal antibody Ki67 (cell proliferation marker) indicate that EVT cells differentiate in vitro by proliferation from the tip of anchoring villi. These mononucleated, round-shaped, migrating cells are HLA-A,B,C class I antigen (W6/32) antibody and low molecular weight cytokeratin positive, and do not immunostain with PAI-1 (plasminogen activator inhibitor) and HPL antibodies. Differentiation of EVT was restricted to first trimester villous tissue; explants from second trimester placentae did not give rise to EVT. Tissue viability as monitored by glucose utilization, lactate, progesterone and hCG production rates correlated with EVT differentiation. The production rates for hCG demonstrated significant variation among individual placentae and was maintained constant for 10 days consistently only in explants cultured on decidual extract supplemented collagen matrix. The described villous tissue culture system may be, therefore, a unique in vitro model to study proliferation and differentiation of EVT from cytotrophoblastic columns, the regulation of EVT proliferation and differentiation, the role of ECM in the induction of the migration and the interaction of extravillous and villous trophoblast at the level of the cytotrophoblastic column.

Entities:  

Mesh:

Year:  1992        PMID: 1470605     DOI: 10.1016/0143-4004(92)90051-t

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  43 in total

1.  Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies.

Authors:  I Caniggia; S Grisaru-Gravnosky; M Kuliszewsky; M Post; S J Lye
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

2.  Placental perivascular cells for human muscle regeneration.

Authors:  Tea Soon Park; Manuela Gavina; Chien-Wen Chen; Bin Sun; Pang-Ning Teng; Johnny Huard; Bridget M Deasy; Ludovic Zimmerlin; Bruno Péault
Journal:  Stem Cells Dev       Date:  2010-11-30       Impact factor: 3.272

3.  Tissue barriers of the human placenta to infection with Toxoplasma gondii.

Authors:  Jennifer R Robbins; Varvara B Zeldovich; Anna Poukchanski; John C Boothroyd; Anna I Bakardjiev
Journal:  Infect Immun       Date:  2011-11-14       Impact factor: 3.441

4.  Quantifying trophoblast migration: In vitro approaches to address in vivo situations.

Authors:  Joanna James; Win Tun; Alys Clark
Journal:  Cell Adh Migr       Date:  2015-10-19       Impact factor: 3.405

5.  Human chorionic gonadotropin stimulates trophoblast invasion through extracellularly regulated kinase and AKT signaling.

Authors:  Johanna Prast; Leila Saleh; Heinrich Husslein; Stefan Sonderegger; Hanns Helmer; Martin Knöfler
Journal:  Endocrinology       Date:  2007-12-06       Impact factor: 4.736

6.  Increased apoptosis in first trimester extravillous trophoblasts from pregnancies at higher risk of developing preeclampsia.

Authors:  Guy St J Whitley; Philip R Dash; Laura-Jo Ayling; Federico Prefumo; Baskaran Thilaganathan; Judith E Cartwright
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

7.  Promotion of human trophoblasts invasion by gonadotropin-releasing hormone (GnRH) I and GnRH II via distinct signaling pathways.

Authors:  Jing Liu; Colin D Maccalman; Yan-ling Wang; Peter C K Leung
Journal:  Mol Endocrinol       Date:  2009-04-16

8.  Isolation and characterization of trophoblasts from enzymatic explants of human term placenta.

Authors:  Tamara D Kolokoltsova; Irina N Saburina; Irina M Zurina; Anastasia A Gorkun; Nastasia V Kosheleva; Vadim S Repin; Rimma A Poltavtseva; Gennady T Sukhikh
Journal:  Hum Cell       Date:  2017-06-13       Impact factor: 4.174

9.  Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer.

Authors:  Mohammad Jaber; Miriam Maoz; Arun Kancharla; Daniel Agranovich; Tamar Peretz; Sorina Grisaru-Granovsky; Beatrice Uziely; Rachel Bar-Shavit
Journal:  Cell Mol Life Sci       Date:  2013-11-01       Impact factor: 9.261

10.  Trophoblast survival signaling during human placentation requires HSP70 activation of MMP2-mediated HBEGF shedding.

Authors:  Chandni V Jain; Philip Jessmon; Charbel T Barrak; Alan D Bolnick; Brian A Kilburn; Michael Hertz; D Randall Armant
Journal:  Cell Death Differ       Date:  2017-07-21       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.